Uporaba lapatiniba: Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs episode artwork

EPISODE · Dec 10, 2022 · 19 MIN

Uporaba lapatiniba: Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs

from Journal Club ULVF

Naša onkologinja Maša Vilfan bo govorila o uporabi lapatiniba: Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs: https://www.nature.com/articles/s41598-021-04229-0

Episode metadata supplied by the publisher feed · Published Dec 10, 2022

Embed this episode

Ready to play

Uporaba lapatiniba: Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs

0:00 19:33

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Journal Club ULVF?

This episode is 19 minutes long.

When was this Journal Club ULVF episode published?

This episode was published on December 10, 2022.

Can I download this Journal Club ULVF episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!